Cronos Group Begins Commercial Production Of CBG Under Modified Ginkgo Agreement

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning announced that it has amended its collaboration and licensing arrangement with that of Ginkgo Bioworks. The amended arrangement has resulted in Cronos beginning the commercial production of CBG as of today.

The arrangement, as demonstrated by the commencement of commercial production of CBG, will enable the acceleration of commercialization of cultured cannabinoids at scale. Effectively, Cronos is now able to begin commercial operations of cultured cannabinoids ahead of the originally stated productivity targets, while incentives for Ginkgo’s are maintained.

With production of CBG beginning today, Cronos now expects to achieve the final productivity target for the cannabinoid by September 2021. Production follows the firm receiving a processing license in April from Health Canada.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The amended arrangement between the two firms effectively establishes milestone events for the early commercialization of products that include target cannabinoids. Now, upon the sale of the first products containing such cannabinoids one-third of common shares in the related tranche are to be released to Ginkgo. Under the terms of the arrangement, up to 14.7 million shares of the issuer are to be issued based on eight separate milestone events, each of which relates to a specific cannabinoid.

Notably, while the first firm to commercially produce CBG from biological manufacturing in Canada, Cronos is not the first such firm to do so globally. Canadian peer Willow Biosciences (TSX: WLLW) beat the company to that milestone event, with Willow commencing the production of CBG at scale back in March.

Cronos Group last traded at $10.36 on the TSX.


Information for this briefing was found via Sedar and Cronos Group. The author has no securities or affiliations related to these organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Cronos Group Sees Adler, Gorenstein Sell Multiple Millions Worth Of Shares

November has been a busy month for Cronos Group (TSX: CRON) (NASDAQ: CRON) in terms...

Thursday, November 19, 2020, 05:36:05 PM

Cronos Group Licenses IP From Aurora Cannabis, 22nd Century Group Related To Biosynthesis

Aurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ:...

Wednesday, December 15, 2021, 09:21:00 AM

Did Cronos Group Management Personally Benefit from the Redwood Acquisition?

This morning, Twitter user @xb0y posted findings related to a potentially undisclosed insider transaction related...

Monday, September 9, 2019, 11:10:04 AM

Cronos Group Posts Revenues of US$7.3 Million For Q4 2019, Loss of US$63.8 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) has finally reported its fourth quarter and full fiscal...

Monday, March 30, 2020, 04:36:32 PM

Cronos Group Posts Fourth Straight Quarter Of Gross Losses In Q3 2020

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported its third quarter financial results for...

Thursday, November 5, 2020, 08:19:42 AM